The thiamin transporter encoded by SLC19A2 and the reduced folate carrier (RFC1) share 40% homology at the protein level, but the thiamin transporter does not mediate transport of folates. By using murine leukemia cell lines that express no, normal, or high levels of RFC1, we demonstrate that RFC1 does not mediate thiamin influx. However, high level RFC1 expression substantially reduced accumulation of the active thiamin coenzyme, thiamin pyrophosphate (TPP). This decreased level of TPP, synthesized intracellularly from imported thiamin, resulted from RFC1-mediated efflux of TPP. The reduced folate carrier (RFC1), 1 first cloned in 1994, mediates transport of reduced folates critical to one carbonrequiring biosynthetic reactions in mammalian cells and is a member of the major facilitator superfamily of transporters (1-3). RFC1 also delivers MTX and new generation antifolates into a variety of tumors, particularly those of hematopoietic origin (4). RFC1 exchanges folates with a broad spectrum of inorganic and organic anions, and high extracellular concentrations of a variety of organic phosphates competitively inhibit RFC1-mediated folate influx (5-7). This interaction between RFC1 and organic phosphates results in the uphill transport of folates into cells linked to the organic phosphate gradient across cell membranes (5).Structurally unrelated to the folates, thiamin plays an essential role in glycolysis and oxidative decarboxylation reactions after conversion to the coenzyme thiamin pyrophosphate by thiamin pyrophosphokinase in cells. Thiamin is also transported across cell membranes by a carrier-mediated process (8). Thiamin deficiency, reflected in a decrease in plasma thiamin concentration and TPP levels in erythrocytes, results in a variety of clinical abnormalities including cardiovascular and neurological disorders (9). Thiamin deficiency due to impaired transport results in the thiamin-responsive megaloblastic anemia syndrome, a disorder also associated with deafness and diabetes mellitus (10, 11). Positional cloning with families inheriting this autosomal recessive disease led to the recent identification of the thiamin transporter gene SLC19A2 (12-14).The thiamin transporter encoded by SLC19A2 is highly homologous to RFC1, sharing an amino acid identity of 40% and similarity of 55%, and both are predicted to have 12 transmembrane domains. Despite the similarity between these two proteins, the thiamin transporter, when expressed in HeLa cells, was not found to transport folates (15). In the current report, the impact of RFC1 function on thiamin transport and accumulation of its active coenzyme metabolites was studied in murine leukemia cells. Although RFC1 was not found to transport thiamin, it does transport phosphorylated thiamin derivatives, thereby modulating the intracellular accumulation of active thiamin metabolites. -[3Ј,5Ј,7-3 H]MTX (5.7 Ci/mmol) and [ 3 H]thiamin hydrochloride (20 Ci/mmol) were obtained from Amersham Pharmacia Biotech, and [ 3 H]TPP (generally labeled, 4.2 Ci/mmol) was custo...